X4 Pharmaceuticals (XFOR) Book Value

Price: $0.1867
Market Cap: $32.42M
Avg Volume: 3.32M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 0.581
52W Range: $0.1701-1.29
Website: X4 Pharmaceuticals

What is X4 Pharmaceuticals's Book Value?

  • X4 Pharmaceuticals's annual Book Value is $22.15M.
  • X4 Pharmaceuticals's quarterly Book Value is $22.15M.

What is Book Value?

Book Value represents the total value of a company's assets that shareholders would theoretically receive if a company were liquidated. It is calculated as the total assets minus intangible assets and total liabilities.

How is Book Value calculated?

Book Value is calculated using the following formula:

Book Value = Total Assets - Intangible Assets - Total Liabilities

Related Metrics

Other important metrics to assess X4 Pharmaceuticals's financial health include:

  • Book Value per Share - measures the per-share value of a company based on its equity:
    • Annual: $0.11
    • Quarterly: $0.11
  • Tangible Book Value per Share - measures the per-share value of a company's tangible assets:
    • Annual: $-0.03
    • Quarterly: $-0.03

These metrics provide insights into X4 Pharmaceuticals's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual Book Value

$22.15M

Quarterly Book Value

$22.15M

X4 Pharmaceuticals Historical Book Value
$150.00M$150.00M$100.00M$100.00M$50.00M$50.00M$0.00$0.00-$50.00M-$50.00M-$100.00M-$100.00MBook Value20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical Book Value per Share
$180.00$180.00$120.00$120.00$60.00$60.00$0.00$0.00$-60.00$-60.00$-120.00$-120.00Book Value per Share20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical Tangible Book Value per Share
$180.00$180.00$120.00$120.00$60.00$60.00$0.00$0.00$-60.00$-60.00$-120.00$-120.00Tangible Book Value per Share20162016201720172018201820192019202020202021202120222022202320232024202420252025

X4 Pharmaceuticals Historical Financial Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.

Year Book Value Book Value Change Book Value per Share Tangible Book Value per Share
2024 $22.15M -56.65% 0.11 -0.03
2023 $51.10M -30.99% 0.29 0.19
2022 $74.05M 14.96% 1.17 0.89
2021 $64.41M -11.52% 2.50 1.83
2020 $72.80M -43.66% 3.63 2.28
2019 $129.22M 498.24% 11.21 8.86
2018 $21.60M -63.21% 47.06 47.06
2017 $58.71M -203.79% 170.84 170.84
2016 $-56.56M 64.80% -60.95 -60.95
2015 $-34.32M N/A -36.98 -36.98

Related Metrics

Explore detailed financial metrics and analysis for XFOR.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio